Status:

RECRUITING

Follitropin Delta in Long GnRH-agonist Protocol

Lead Sponsor:

Prof. Dr. med. M.Sc. Georg Griesinger

Collaborating Sponsors:

University Hopsital Schleswig Holstein Campus Lübeck

Conditions:

Infertility (IVF Patients)

Infertility

Eligibility:

FEMALE

18-44 years

Brief Summary

The REWAG study ("Real-world Evaluation of Women undergoing Agonist protocol with Follitropin delta") is a non-interventional observational study conducted across several fertility centers in Germany....

Eligibility Criteria

Inclusion

  • Age ≥18 to ≤ 44 years at enrolment
  • Planned stimulation in a long luteal GnRH agonist protocol with daily s.c. GnRH-agonist
  • Planned use of Fd for ovarian stimulation as per SmPC
  • Serum AMH ≥0.3 ng/ml to ≤4.9 ng/ml measured within12 months prior to treatment
  • Most recent serum AMH value before start of stimulation not older than 12 months
  • Planned IVF or ICSI treatment in a first or second attempt with ejaculated or cryopreserved male germ cells, autologous or heterologous, with or without planned genetic testing of the oocytes or embryos
  • Planned triggering of final oocyte maturation with hCG
  • Willingness and consent to participate

Exclusion

  • Serum AMH value not determined in ELECSYS AMH Plus Immunoassay, ACCESS AMH Advanced (Beckham Coulter) or LUMIPULSE G AMH (Fujirebio)
  • Most recent serum AMH value before start of stimulation older than 12 months
  • Serum AMH within 12 months prior to treatment AMH ≤ 0.3 ng/ml or ≥4.9 ng/ml measured within 12 months prior to treatment
  • Pre-treatment with a combined oral contraceptive "pill" consisting of ethinyl estradiol and a synthetic progestogen or a natural estradiol/progesterone
  • Anovulatory PCOS syndrome
  • Women with a contraindication for prescription of Fd treatment
  • Women undergoing ovarian stimulation for fertility preservation

Key Trial Info

Start Date :

July 9 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2027

Estimated Enrollment :

350 Patients enrolled

Trial Details

Trial ID

NCT06995261

Start Date

July 9 2025

End Date

December 1 2027

Last Update

July 29 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Department of Obstetrics, Gynecology and Reproductive Endocrinology (UniKiD), Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf

Düsseldorf, North Rhine-Westphalia, Germany, 40225

2

Center for Reproductive Medicine, IVF SAAR

Saarbrücken, Saarland, Germany, 66113

3

Department of Reproductive Medicine and Gynecological Endocrinology, University Hospital of Schleswig-Holstein, Campus Kiel

Kiel, Schleswig-Holstein, Germany, 24105

4

Department of Reproductive Medicine and Gynecological Endocrinology, University Hospital of Schleswig-Holstein, Campus Lübeck

Lübeck, Schleswig-Holstein, Germany, 23538